157 related articles for article (PubMed ID: 22435351)
1. Panax ginseng may improve some symptoms of attention-deficit hyperactivity disorder.
Niederhofer H
J Diet Suppl; 2009; 6(1):22-7. PubMed ID: 22435351
[TBL] [Abstract][Full Text] [Related]
2. Observational study: Matricaria chamomilla may improve some symptoms of attention-deficit hyperactivity disorder.
Niederhofer H
Phytomedicine; 2009 Apr; 16(4):284-6. PubMed ID: 19097772
[TBL] [Abstract][Full Text] [Related]
3. St. John's wort may improve some symptoms of attention-deficit hyperactivity disorder.
Niederhofer H
Nat Prod Res; 2010 Feb; 24(3):203-5. PubMed ID: 20140799
[TBL] [Abstract][Full Text] [Related]
4. Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study.
Lyon MR; Cline JC; Totosy de Zepetnek J; Shan JJ; Pang P; Benishin C
J Psychiatry Neurosci; 2001 May; 26(3):221-8. PubMed ID: 11394191
[TBL] [Abstract][Full Text] [Related]
5. Tianeptine as a slightly effective therapeutic option for attention-deficit hyperactivity disorder.
Niederhofer H
Neuropsychobiology; 2004; 49(3):130-3. PubMed ID: 15034228
[TBL] [Abstract][Full Text] [Related]
6. Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.
Park P; Caballero J; Omidian H
Ann Pharmacother; 2014 Jan; 48(1):86-92. PubMed ID: 24259607
[TBL] [Abstract][Full Text] [Related]
7. Effects of Korean red ginseng extract on behavior in children with symptoms of inattention and hyperactivity/impulsivity: a double-blind randomized placebo-controlled trial.
Ko HJ; Kim I; Kim JB; Moon Y; Whang MC; Lee KM; Jung SP
J Child Adolesc Psychopharmacol; 2014 Nov; 24(9):501-8. PubMed ID: 25369174
[TBL] [Abstract][Full Text] [Related]
8. Ginkgo biloba treating patients with attention-deficit disorder.
Niederhofer H
Phytother Res; 2010 Jan; 24(1):26-7. PubMed ID: 19441138
[TBL] [Abstract][Full Text] [Related]
9. Immediate-release methylphenidate for attention deficit hyperactivity disorder (ADHD) in adults.
Cândido RCF; Menezes de Padua CA; Golder S; Junqueira DR
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD013011. PubMed ID: 33460048
[TBL] [Abstract][Full Text] [Related]
10. Improvement with duloxetine in an adult ADHD patient.
Tourjman SV; Bilodeau M
J Atten Disord; 2009 Jul; 13(1):95-6. PubMed ID: 19359667
[TBL] [Abstract][Full Text] [Related]
11. An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder.
Hunt RD; Arnsten AF; Asbell MD
J Am Acad Child Adolesc Psychiatry; 1995 Jan; 34(1):50-4. PubMed ID: 7860456
[TBL] [Abstract][Full Text] [Related]
12. Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit/hyperactivity disorder.
Spencer T; Heiligenstein JH; Biederman J; Faries DE; Kratochvil CJ; Conners CK; Potter WZ
J Clin Psychiatry; 2002 Dec; 63(12):1140-7. PubMed ID: 12523874
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of atomoxetine in childhood attention-deficit/hyperactivity disorder with comorbid oppositional defiant disorder.
Kaplan S; Heiligenstein J; West S; Busner J; Harder D; Dittmann R; Casat C; Wernicke JF
J Atten Disord; 2004 Oct; 8(2):45-52. PubMed ID: 15801334
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Omega-3 and Korean Red Ginseng in Children with Subthreshold ADHD: A Double-Blind, Randomized, Placebo-Controlled Trial.
Lee J; Lee SI
J Atten Disord; 2021 Dec; 25(14):1977-1987. PubMed ID: 32847461
[TBL] [Abstract][Full Text] [Related]
15. Clinical effects of korean red ginseng on attention deficit hyperactivity disorder in children: an observational study.
Lee SH; Park WS; Lim MH
J Ginseng Res; 2011 Jun; 35(2):226-34. PubMed ID: 23717065
[TBL] [Abstract][Full Text] [Related]
16. Duloxetine in the treatment of adolescents with attention deficit/hyperactivity disorder: an open-label study.
Mahmoudi-Gharaei J; Dodangi N; Tehrani-Doost M; Faghihi T
Hum Psychopharmacol; 2011 Mar; 26(2):155-60. PubMed ID: 21455975
[TBL] [Abstract][Full Text] [Related]
17. A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831).
Kean JD; Kaufman J; Lomas J; Goh A; White D; Simpson D; Scholey A; Singh H; Sarris J; Zangara A; Stough C
Nutrients; 2015 Dec; 7(12):9931-45. PubMed ID: 26633481
[TBL] [Abstract][Full Text] [Related]
18. [Attention-deficit/hyperactivity disorder (ADHS) in adulthood].
Kordon A; Kahl KG
Psychother Psychosom Med Psychol; 2004; 54(3-4):124-36. PubMed ID: 15037976
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine in children and adolescents with attention deficit hyperactivity disorder.
Mukaddes NM; Abali O
Psychiatry Clin Neurosci; 2004 Feb; 58(1):92-5. PubMed ID: 14678464
[TBL] [Abstract][Full Text] [Related]
20. Antidepressants in the treatment of adult attention-deficit hyperactivity disorder: a systematic review.
Verbeeck W; Tuinier S; Bekkering GE
Adv Ther; 2009 Feb; 26(2):170-84. PubMed ID: 19238340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
